The expensive medication does little to prevent hospitalisation or death for people who are vaccinated against the virus, a ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

A document the Department of Health and Human Services distributed to members of Congress to justify recent changes to ...

Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...

COVID-19 patients who are vaccinated -- and were hospitalized with reduced kidney function -- had better outcomes than ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

Meissner was previously listed in April as a consultant to the RSV vaccines work group for the CDC committee, before Kennedy ...

Last month, an average of about 350 people died each week from COVID, according to data from the CDC. With available vaccines ...

The Ministry of Health has announced that the updated Pfizer-BioNTech Covid-19 vaccine, targeting the JN.1 variant, is now available in Bermuda by appointment. A Government spokesperson said, “The ...

Researchers examined which participants developed kidney disease severe enough to require a dialysis known as continuous ...

Vaccinated COVID-19 patients with acute kidney injury face lower mortality and dialysis risks than unvaccinated patients.